The Board of Directors of Novogene Co., Ltd. has authorized a buyback plan on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.57 CNY | +2.18% | +5.93% | -41.86% |
Apr. 12 | Novogene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 27 | Novogene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.86% | 773M | |
-16.80% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-6.54% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-14.42% | 1.03B |
- Stock Market
- Equities
- 688315 Stock
- News Novogene Co., Ltd.
- Novogene Co., Ltd. authorizes a Buyback Plan.